Talus Bio

About:

Talus Bio is a drug discovery biotech company that develops drugs targeting undruggable transcription factors using AI.

Website: https://www.talus.bio

Twitter/X: talusbio

Top Investors: National Institutes of Health, National Science Foundation, Y Combinator, NFX, FundersClub

Description:

Talus Bio is a drug discovery biotech startup working on drug development for gene regulators. The company integrates functional proteomics, automated biology, and machine learning to target challenging cancer transcription factors. The MARMOT (Multiplexed Assays for the Rational Modulation Of Transcription Factors) platform, developed by the company, leverages AI, advanced proteomics, synthetic chemistry, and computational biology to design and analyze drugs, proteins, and genomics in a groundbreaking manner.

Total Funding Amount:

$27.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2020-07-13

Contact Email:

info(AT)talus.bio

Founders:

Alex Federation, Lindsay Pino

Number of Employees:

11-50

Last Funding Date:

2024-08-20

IPO Status:

Private

© 2024 MyAiNote.com